BPR1M97
BPR1M97 is a dual-acting mu opioid receptor (MOP) and nociceptin-orphanin FQ peptide (NOP) receptor agonist with Ki values of 1.8 and 4.2 nM, respectively. BPR1M97 shows high potency and blood-brain barrier penetration, and produces potent antinociceptive effects[1].
Product Specifications
CAS Number
2059904-66-2
UNSPSC
12352005
Target
Opioid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bpr1m97.html
Purity
99.42
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(NCC1N(C)CCC2=C1C=CC=C2)C3=CC=C(Cl)C(Cl)=C3
Molecular Formula
C18H18Cl2N2O
Molecular Weight
349.25
References & Citations
[1]Chao PK, et al. BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, producespotent antinociceptive effects with safer properties than morphine. Neuropharmacology. 2019 Jul 3:107678.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
μ Opioid Receptor/MOR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
15989121 3x 1.0µg DNA
CFLAR CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 
CCDC132-1306M 50 µg
Recombinant Mouse CCDC132 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details 
orb2918445-01 20 µg
Recombinant Zygosaccharomyces rouxii Autophagy-related protein 33 (ATG33)
Sign In for Pricing
View Details orb2918445-02 100 µg
Recombinant Zygosaccharomyces rouxii Autophagy-related protein 33 (ATG33)
Sign In for Pricing
View Details L2601-05G-ML405 100 µL
LPR1, phosphorylated (Ser452) (Prolow-density Lipoprotein Receptor-related Protein 1, LRP-1, Alpha-2-macroglobulin Receptor, A2MR, Apolipoprotein E Receptor, APOER, CD91, APR) (MaxLight 405) discontinued
Sign In for Pricing
View Details 